Mobility LimitationStepping-UpNCT04368949
Stepping-Up: Partnering With the Community to Prevent Early Mobility Decline
A study testing Stepping-Up, Telephone-Based Coaching Walking Program and Chair-Based Yoga Program in people with Mobility Limitation, run by McMaster University at 1 site in Canada.
Trial summary
Preclinical mobility limitations (PCML) manifest early in the process of declining mobility, and are not typically identified or acted upon by clinicians. These mobility limitations manifest as changes in how daily tasks such as walking are performed (slower speed, lower endurance). Read more about this study
- Who is it for?
- Ages 55 to 75 yearsHealthy volunteers can take part
- Conditions the study is for
- Mobility Limitation
- What is being tested?
- Stepping-Up, Telephone-Based Coaching Walking Program and Chair-Based Yoga Program
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 249 participants
- Where
- 1 siteCanada
- Study dates
- 1 Apr 2021to 31 Mar 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 55 to 75 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Community-dwelling
- Age ≥55-75 years
- PCML as assessed using a questionnaire that requires respondents to self-report difficulties with their mobility (walking 2.0km). Respondents will be considered in a stage of PCML if they report no task difficulty but report modification of task performance (i.e. modify frequency, method or time to complete the task)
- Understanding of spoken and written English
- Own a laptop computer, have an email address and have internet capabilities of running the video-conferencing platform, Zoom©.
- Resident of Ontario, Canada
Who cannot join
- A score of <11 on the MoCA 5-Minute telephone screen
- Major illness that would prevent participation
Trial locations and contacts
1 site in 1 country.
About this study
Preclinical mobility limitations (PCML) manifest early in the process of declining mobility, and are not typically identified or acted upon by clinicians. These mobility limitations manifest as changes in how daily tasks such as walking are performed (slower speed, lower endurance). Persons in the PCML stage are at increased risk for the onset of disability and chronic disease. Persistent deterioration in mobility is a predictor of mortality and has been reported even in the absence of changes in activities of daily living over a two-year period. Further, older persons with mobility limitations, including reduced gait speed, are at risk for falls. These cumulative transitions of a person's life-long mobility form their mobility trajectory and preventing mobility decline at an early stage along this trajectory is the focus of this research initiative. This study will evaluate a novel intervention, STEPPING-UP, for improving walking ability in persons with PCML.
- Conditions
- Mobility Limitation
- Being tested
- Stepping-Up, Telephone-Based Coaching Walking Program, Chair-Based Yoga Program
- Keywords
- Preclinical mobility limitation, Walking ability, Physical function, Task-oriented motor learning, Self-management
- Medical subject headings
- Mobility Limitation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Stepping-UpOther
The intervention group will receive STEPPING-UP, a virtual 12-week, multicomponent intervention that includes tailored task-oriented motor learning exercise and a mobility self-management (SM) program.
Telephone-Based Coaching Walking ProgramOther
The participants assigned to this group will receive a 12-week Telephone-Based Coaching Walking Program (TELE) delivered by a PT who will help participants set short and long term walking goals.
Chair-Based Yoga ProgramOther
Participants assigned to this group will receive a virtual 12-week Chair-Based Yoga Program (YOGA), a group-based exercise control where participants will undertake a seated exercise program that includes: warm up, seated and standing yoga poses, cool down.
| Study group | Role | What they receive |
|---|---|---|
| Stepping-Up Group | Experimental | Participants will attend one 2-hour virtual session (1-hour exercise and 1-hour SM) per week. Each class of 6-8 participants is supervised by a Physiotherapist (PT) and kinesiologist who will individually tailor the exercises for each participant. Receives: Other: Stepping-Up |
| TELE Group | Active comparator | The initial telephone session will be 20-30 minutes, with subsequent weekly calls will be approximately 10 minutes. Receives: Other: Telephone-Based Coaching Walking Program |
| Chair-Based Yoga Group | Placebo comparator | Participants will attend two 1-hour virtual sessions per week to ensure this group is matched for attention to STEPPING-UP. Receives: Other: Chair-Based Yoga Program |
What is being measured
The primary outcome is the main question the study is designed to answer.
Walking speed
The 4-Metre Gait Speed Test (4MGS) is a performance-based measure of walking speed. The 4MGS test will be performed from a standing start at both a self-selected (usual) and fastest walking speed.
Measured: Baseline
Change in walking speed from baseline
The 4-Metre Gait Speed Test (4MGS) is a performance-based measure of walking speed. The 4MGS test will be performed from a standing start at both a self-selected (usual) and fastest walking speed.
Measured: 12 weeks
Secondary outcomes (60)
Change in walking speed from baseline
The 4-Metre Gait Speed Test (4MGS) is a performance-based measure of walking speed. The 4MGS test will be performed from a standing start at both a self-selected (usual) and fastest walking speed.
Measured: 24 weeks
Change in walking speed from baseline
The 4-Metre Gait Speed Test (4MGS) is a performance-based measure of walking speed. The 4MGS test will be performed from a standing start at both a self-selected (usual) and fastest walking speed.
Measured: 36 weeks
Exercise capacity
2-Minute Step Test (TMST): The TMST is a test of exercise capacity that can be used as an alternative to a timed long-distance walking test when assessment space is limited. Individuals are required to march in place as quickly as possible for 2 minutes while lifting their knees to a height midway between their patella and iliac crest when standing.
Measured: Baseline
Change in exercise capacity from baseline
2-Minute Step Test (TMST): The TMST is a test of exercise capacity that can be used as an alternative to a timed long-distance walking test when assessment space is limited. Individuals are required to march in place as quickly as possible for 2 minutes while lifting their knees to a height midway between their patella and iliac crest when standing.
Measured: 12 weeks
Change in exercise capacity from baseline
2-Minute Step Test (TMST): The TMST is a test of exercise capacity that can be used as an alternative to a timed long-distance walking test when assessment space is limited. Individuals are required to march in place as quickly as possible for 2 minutes while lifting their knees to a height midway between their patella and iliac crest when standing.
Measured: 24 weeks
Change in exercise capacity from baseline
2-Minute Step Test (TMST): The TMST is a test of exercise capacity that can be used as an alternative to a timed long-distance walking test when assessment space is limited. Individuals are required to march in place as quickly as possible for 2 minutes while lifting their knees to a height midway between their patella and iliac crest when standing.
Measured: 36 weeks
Lower body strength
30-Second Chair Stand Test (CST): The 30-Second CST is used to assess lower body strength and power and is measured by the number of chair stand repetitions in a 30-second period.
Measured: Baseline
Change in lower body strength from baseline
30-Second Chair Stand Test (CST): The 30-Second CST is used to assess lower body strength and power and is measured by the number of chair stand repetitions in a 30-second period.
Measured: 12 weeks
Change in lower body strength from baseline
30-Second Chair Stand Test (CST): The 30-Second CST is used to assess lower body strength and power and is measured by the number of chair stand repetitions in a 30-second period.
Measured: 24 weeks
Change in lower body strength from baseline
30-Second Chair Stand Test (CST): The 30-Second CST is used to assess lower body strength and power and is measured by the number of chair stand repetitions in a 30-second period.
Measured: 36 weeks
Dual task cost
Difference in time between the Timed Up and Go (TUG) and the TUG Cognitive.
Measured: Baseline
Change in dual task cost from baseline
Difference in time between the Timed Up and Go (TUG) and the TUG Cognitive.
Measured: 12 weeks
Change in dual task cost from baseline
Difference in time between the Timed Up and Go (TUG) and the TUG Cognitive.
Measured: 24 weeks
Change in dual task cost from baseline
Difference in time between the Timed Up and Go (TUG) and the TUG Cognitive.
Measured: 36 weeks
Self-reported change in mobility
Global Mobility Change Rating: A single question, ''Since your last visit, has there been any change in your mobility?'' will be asked. The response will be made on a 11-point self-reported Likert scale: - 5 = very much worse; 0 = unchanged; 5 = very much better.
Measured: 12 weeks
Change in self-reported change in mobility from basseline
Global Mobility Change Rating: A single question, ''Since your last visit, has there been any change in your mobility?'' will be asked. The response will be made on a 11-point self-reported Likert scale: - 5 = very much worse; 0 = unchanged; 5 = very much better.
Measured: 24 weeks
Change in self-reported change in mobility from basseline
Global Mobility Change Rating: A single question, ''Since your last visit, has there been any change in your mobility?'' will be asked. The response will be made on a 11-point self-reported Likert scale: - 5 = very much worse; 0 = unchanged; 5 = very much better.
Measured: 36 weeks
Balance self-efficacy
Activities-specific Balance Confidence (ABC) Scale: The ABC Scale is a self-report measure of balance confidence. Individuals are asked to rate their confidence in completing 16 common tasks without losing balance, on a scale from 0% (no confidence) to 100% (complete confidence).
Measured: Baseline
Change in balance self-efficacy from baseline
Activities-specific Balance Confidence (ABC) Scale: The ABC Scale is a self-report measure of balance confidence. Individuals are asked to rate their confidence in completing 16 common tasks without losing balance, on a scale from 0% (no confidence) to 100% (complete confidence).
Measured: 12 weeks
Change in balance self-efficacy from baseline
Activities-specific Balance Confidence (ABC) Scale: The ABC Scale is a self-report measure of balance confidence. Individuals are asked to rate their confidence in completing 16 common tasks without losing balance, on a scale from 0% (no confidence) to 100% (complete confidence).
Measured: 24 weeks
Change in balance self-efficacy from baseline
Activities-specific Balance Confidence (ABC) Scale: The ABC Scale is a self-report measure of balance confidence. Individuals are asked to rate their confidence in completing 16 common tasks without losing balance, on a scale from 0% (no confidence) to 100% (complete confidence).
Measured: 36 weeks
Mobility patterns
The Life-Space Assessment (LSA): The LSA measures a person's usual pattern of mobility during a 1-month period, documenting mobility based on how far and how often a person travels and any assistance required.
Measured: Baseline
Change in mobility patterns from baseline
The Life-Space Assessment (LSA): The LSA measures a person's usual pattern of mobility during a 1-month period, documenting mobility based on how far and how often a person travels and any assistance required.
Measured: 12 weeks
Change in mobility patterns from baseline
The Life-Space Assessment (LSA): The LSA measures a person's usual pattern of mobility during a 1-month period, documenting mobility based on how far and how often a person travels and any assistance required.
Measured: 24 weeks
Change in mobility patterns from baseline
The Life-Space Assessment (LSA): The LSA measures a person's usual pattern of mobility during a 1-month period, documenting mobility based on how far and how often a person travels and any assistance required.
Measured: 36 weeks
Knowledge, skill and confidence for self-management
Patient Activation Measure (PAM): The PAM is a 13-item measure of the patient's level of knowledge, skill and confidence for SM. An Activation Score is calculated as the sum of the 13 items. The Activation Score can then be converted into an Activation Level (Level 1 = low activation, Level 4 = high activation).
Measured: 12 weeks
Change in knowledge, skill and confidence for self-management from baseline
Patient Activation Measure (PAM): The PAM is a 13-item measure of the patient's level of knowledge, skill and confidence for SM. An Activation Score is calculated as the sum of the 13 items. The Activation Score can then be converted into an Activation Level (Level 1 = low activation, Level 4 = high activation).
Measured: Baseline
Change in knowledge, skill and confidence for self-management from baseline
Patient Activation Measure (PAM): The PAM is a 13-item measure of the patient's level of knowledge, skill and confidence for SM. An Activation Score is calculated as the sum of the 13 items. The Activation Score can then be converted into an Activation Level (Level 1 = low activation, Level 4 = high activation).
Measured: 24 weeks
Change in knowledge, skill and confidence for self-management from baseline
Patient Activation Measure (PAM): The PAM is a 13-item measure of the patient's level of knowledge, skill and confidence for SM. An Activation Score is calculated as the sum of the 13 items. The Activation Score can then be converted into an Activation Level (Level 1 = low activation, Level 4 = high activation).
Measured: 36 weeks
Balance
Unipedal Stance Test (UPST): The UPST is used to assess static balance. 68 Individuals are asked to stand barefoot on the limb of their choice until they (1) use their arms (i.e., uncross arms), (2) use their raised foot (i.e., move it toward or away from the standing limb or touched the floor), (3) move the weight-bearing foot to maintain their balance (i.e., rotate foot on the ground) or (4) maintain the position for a maximum of 45 seconds.
Measured: Baseline
Change in balance from baseline
Unipedal Stance Test (UPST): The UPST is used to assess static balance. 68 Individuals are asked to stand barefoot on the limb of their choice until they (1) use their arms (i.e., uncross arms), (2) use their raised foot (i.e., move it toward or away from the standing limb or touched the floor), (3) move the weight-bearing foot to maintain their balance (i.e., rotate foot on the ground) or (4) maintain the position for a maximum of 45 seconds.
Measured: 12 weeks
Change in balance from baseline
Unipedal Stance Test (UPST): The UPST is used to assess static balance. 68 Individuals are asked to stand barefoot on the limb of their choice until they (1) use their arms (i.e., uncross arms), (2) use their raised foot (i.e., move it toward or away from the standing limb or touched the floor), (3) move the weight-bearing foot to maintain their balance (i.e., rotate foot on the ground) or (4) maintain the position for a maximum of 45 seconds.
Measured: 24 weeks
Change in balance from baseline
Unipedal Stance Test (UPST): The UPST is used to assess static balance. 68 Individuals are asked to stand barefoot on the limb of their choice until they (1) use their arms (i.e., uncross arms), (2) use their raised foot (i.e., move it toward or away from the standing limb or touched the floor), (3) move the weight-bearing foot to maintain their balance (i.e., rotate foot on the ground) or (4) maintain the position for a maximum of 45 seconds.
Measured: 36 weeks
Health-related quality of life
EQ-5D-5L is a generic utility-based health related quality of life questionnaire. Respondents are asked to rate 5 dimensions of their health: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The five response levels are:no problems (1), slight problems (2), moderate problems (3), severe problems (4), unable to /extreme problems (5).
Measured: Baseline
Change in health-related quality of life from baseline
EQ-5D-5L is a generic utility-based health related quality of life questionnaire. Respondents are asked to rate 5 dimensions of their health: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The five response levels are:no problems (1), slight problems (2), moderate problems (3), severe problems (4), unable to /extreme problems (5).
Measured: 12 weeks
Change in health-related quality of life from baseline
EQ-5D-5L is a generic utility-based health related quality of life questionnaire. Respondents are asked to rate 5 dimensions of their health: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The five response levels are:no problems (1), slight problems (2), moderate problems (3), severe problems (4), unable to /extreme problems (5).
Measured: 24 weeks
Change in health-related quality of life from baseline
EQ-5D-5L is a generic utility-based health related quality of life questionnaire. Respondents are asked to rate 5 dimensions of their health: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The five response levels are:no problems (1), slight problems (2), moderate problems (3), severe problems (4), unable to /extreme problems (5).
Measured: 36 weeks
Self-efficacy for physical activity:
Participants will be asked to rate how confident they are that they could participate in moderate intensity physical activity for 150 minutes per week using a single question on a scale of 1-10. Higher values indicate greater self-efficacy.
Measured: Baseline
Change in self-efficacy for physical activity from baseline
Participants will be asked to rate how confident they are that they could participate in moderate intensity physical activity for 150 minutes per week using a single question on a scale of 1-10. Higher values indicate greater self-efficacy.
Measured: 12 weeks
Change in self-efficacy for physical activity from baseline
Participants will be asked to rate how confident they are that they could participate in moderate intensity physical activity for 150 minutes per week using a single question on a scale of 1-10. Higher values indicate greater self-efficacy.
Measured: 24 weeks
Change in self-efficacy for physical activity from baseline
Participants will be asked to rate how confident they are that they could participate in moderate intensity physical activity for 150 minutes per week using a single question on a scale of 1-10. Higher values indicate greater self-efficacy.
Measured: 36 weeks
Self-reported mobility
Mobility Assessment Tool (MAT-sf): The MAT-sf is a video-animated tool for assessing mobility. It consists of 10 animated video clips that assess an individuals' perceived level of proficiency in performing each task.
Measured: Baseline
Change in self-reported mobility from baseline
Mobility Assessment Tool (MAT-sf): The MAT-sf is a video-animated tool for assessing mobility. It consists of 10 animated video clips that assess an individuals' perceived level of proficiency in performing each task.
Measured: 12 weeks
Change in self-reported mobility from baseline
Mobility Assessment Tool (MAT-sf): The MAT-sf is a video-animated tool for assessing mobility. It consists of 10 animated video clips that assess an individuals' perceived level of proficiency in performing each task.
Measured: 24 weeks
Change in self-reported mobility from baseline
Mobility Assessment Tool (MAT-sf): The MAT-sf is a video-animated tool for assessing mobility. It consists of 10 animated video clips that assess an individuals' perceived level of proficiency in performing each task.
Measured: 36 weeks
Emergency room visits
Healthcare utilization data collected using self-report self-report.
Measured: Baseline to 12 weeks
Emergency room visits
Healthcare utilization data collected using self-report self-report.
Measured: 12 weeks to 24 weeks
Emergency room visits
Healthcare utilization data collected using self-report self-report.
Measured: 24 weeks to 36 weeks
Hospitalizations
Healthcare utilization data collected using self-report self-report.
Measured: Baseline to 12 weeks
Hospitalizations
Healthcare utilization data collected using self-report self-report.
Measured: 12 weeks to 24 weeks
Hospitalizations
Healthcare utilization data collected using self-report self-report.
Measured: 24 weeks to 36 weeks
Family doctor visits
Healthcare utilization data collected using self-report self-report.
Measured: Baseline to 12 weeks
Family doctor visits
Healthcare utilization data collected using self-report self-report.
Measured: 12 weeks to 24 weeks
Family doctor visits
Healthcare utilization data collected using self-report self-report.
Measured: 24 weeks to 36 weeks
Specialist physician visits visits
Healthcare utilization data collected using self-report self-report.
Measured: Baseline to 12 weeks
Specialist physician visits visits
Healthcare utilization data collected using self-report self-report.
Measured: 12 weeks to 24 weeks
Specialist physician visits visits
Healthcare utilization data collected using self-report self-report.
Measured: 24 weeks to 36 weeks
Medical tests or procedures
Healthcare utilization data collected using self-report self-report.
Measured: Baseline to 12 weeks
Medical tests or procedures
Healthcare utilization data collected using self-report self-report.
Measured: 12 weeks to 24 weeks
Medical tests or procedures
Healthcare utilization data collected using self-report self-report.
Measured: 24 weeks to 36 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Apr 2020
- Study start1 Apr 2021
- Primary completion1 Oct 2025
- Study completion31 Mar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Mobility LimitationStudies of the same condition, open and under way.
- More trials run by McMaster UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 249 participants (estimated)
Sponsor and investigators
- Lead sponsor
- McMaster University
- Sponsor type
- University, hospital or other
- Collaborators
- YMCA Hamilton/Burlington/Brantford, City of Hamilton
- Responsible party
- Principal investigator, Julie Richardson, McMaster University
- Investigators
- Julie Richardson, PhD, Principal investigator, McMaster UniversityAyse Kuspinar, PhD, Principal investigator, McMaster University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04368949
- Sponsor's protocol ID
- PJT-169034
- Acronym
- Stepping-Up
- Status last verified
- Jun 2026
- First submitted
- 23 Apr 2020
- Last updated
- 17 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Richardson J, Kuspinar A, Sinclair S, Beauchamp M, Dufour S, Tang A, MacDermid J, Durocher E, Thabane L, Xie F, Costa A. Effect of an Online Mobility Self-Management Program on Walking Speed in Older Adults With Preclinical Mobility Limitation: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2025 May 21;14:e72585. doi: 10.2196/72585.
PubMed 40397951
Study at a glance
From the registry record, last updated by the sponsor on 17 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Stepping-Up: Partnering With the Community to Prevent Early Mobility Decline
- ClinicalTrials.gov ID
- NCT04368949
- Acronym / sponsor ID
- Stepping-Up / PJT-169034
- Conditions
- Mobility Limitation
- Keywords
- Preclinical mobility limitation, Walking ability, Physical function, Task-oriented motor learning, Self-management
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 249 participants (estimated)
- Lead sponsor
- McMaster UniversityUniversity, hospital or other
- Collaborators
- YMCA Hamilton/Burlington/Brantford, City of Hamilton
- Study start
- 1 Apr 2021 (actual)
- Primary completion
- 1 Oct 2025 (actual)
- Study completion
- 31 Mar 2027 (estimated)
- First posted
- 30 Apr 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Preclinical mobility limitations (PCML) manifest early in the process of declining mobility, and are not typically identified or acted upon by clinicians. These mobility limitations manifest as changes in how daily tasks such as walking are performed (slower speed, lower endurance). Persons in the PCML stage are at increased risk for the onset of disability and chronic disease. Persistent deterioration in mobility is a predictor of mortality and has been reported even in the absence of changes in activities of daily living over a two-year period. Further, older persons with mobility limitations, including reduced gait speed, are at risk for falls. These cumulative transitions of a person's life-long mobility form their mobility trajectory and preventing mobility decline at an early stage along this trajectory is the focus of this research initiative. This study will evaluate a novel intervention, STEPPING-UP, for improving walking ability in persons with PCML.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Stepping-Up Group | Experimental | Other: Stepping-UpParticipants will attend one 2-hour virtual session (1-hour exercise and 1-hour SM) per week. Each class of 6-8 participants is supervised by a Physiotherapist (PT) and kinesiologist who will individually tailor the exercises for each participant. |
| TELE Group | Active comparator | Other: Telephone-Based Coaching Walking ProgramThe initial telephone session will be 20-30 minutes, with subsequent weekly calls will be approximately 10 minutes. |
| Chair-Based Yoga Group | Placebo comparator | Other: Chair-Based Yoga ProgramParticipants will attend two 1-hour virtual sessions per week to ensure this group is matched for attention to STEPPING-UP. |
Who may qualify
- Ages
- 55 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Community-dwelling
- Age ≥55-75 years
- PCML as assessed using a questionnaire that requires respondents to self-report difficulties with their mobility (walking 2.0km). Respondents will be considered in a stage of PCML if they report no task difficulty but report modification of task performance (i.e. modify frequency, method or time to complete the task)
- Understanding of spoken and written English
- Own a laptop computer, have an email address and have internet capabilities of running the video-conferencing platform, Zoom©.
Key exclusion criteria (2 listed)
- A score of <11 on the MoCA 5-Minute telephone screen
- Major illness that would prevent participation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Stepping-UpThe intervention group will receive STEPPING-UP, a virtual 12-week, multicomponent intervention that includes tailored task-oriented motor learning exercise and a mobility self-management (SM) program. | Other | Stepping-Up Group |
| Telephone-Based Coaching Walking ProgramThe participants assigned to this group will receive a 12-week Telephone-Based Coaching Walking Program (TELE) delivered by a PT who will help participants set short and long term walking goals. | Other | TELE Group |
| Chair-Based Yoga ProgramParticipants assigned to this group will receive a virtual 12-week Chair-Based Yoga Program (YOGA), a group-based exercise control where participants will undertake a seated exercise program that includes: warm up, seated and standing yoga poses, cool down. | Other | Chair-Based Yoga Group |
Primary outcome
Walking speed
Time frame: Baseline
The 4-Metre Gait Speed Test (4MGS) is a performance-based measure of walking speed. The 4MGS test will be performed from a standing start at both a self-selected (usual) and fastest walking speed.
Change in walking speed from baseline
Time frame: 12 weeks
The 4-Metre Gait Speed Test (4MGS) is a performance-based measure of walking speed. The 4MGS test will be performed from a standing start at both a self-selected (usual) and fastest walking speed.
60 secondary outcomes
Change in walking speed from baseline
Time frame: 24 weeks
Change in walking speed from baseline
Time frame: 36 weeks
Exercise capacity
Time frame: Baseline
Change in exercise capacity from baseline
Time frame: 12 weeks
Change in exercise capacity from baseline
Time frame: 24 weeks
Change in exercise capacity from baseline
Time frame: 36 weeks
Lower body strength
Time frame: Baseline
Change in lower body strength from baseline
Time frame: 12 weeks
Change in lower body strength from baseline
Time frame: 24 weeks
Change in lower body strength from baseline
Time frame: 36 weeks
Dual task cost
Time frame: Baseline
Change in dual task cost from baseline
Time frame: 12 weeks
Change in dual task cost from baseline
Time frame: 24 weeks
Change in dual task cost from baseline
Time frame: 36 weeks
Self-reported change in mobility
Time frame: 12 weeks
Change in self-reported change in mobility from basseline
Time frame: 24 weeks
Change in self-reported change in mobility from basseline
Time frame: 36 weeks
Balance self-efficacy
Time frame: Baseline
Change in balance self-efficacy from baseline
Time frame: 12 weeks
Change in balance self-efficacy from baseline
Time frame: 24 weeks
Change in balance self-efficacy from baseline
Time frame: 36 weeks
Mobility patterns
Time frame: Baseline
Change in mobility patterns from baseline
Time frame: 12 weeks
Change in mobility patterns from baseline
Time frame: 24 weeks
Change in mobility patterns from baseline
Time frame: 36 weeks
Knowledge, skill and confidence for self-management
Time frame: 12 weeks
Change in knowledge, skill and confidence for self-management from baseline
Time frame: Baseline
Change in knowledge, skill and confidence for self-management from baseline
Time frame: 24 weeks
Change in knowledge, skill and confidence for self-management from baseline
Time frame: 36 weeks
Balance
Time frame: Baseline
Change in balance from baseline
Time frame: 12 weeks
Change in balance from baseline
Time frame: 24 weeks
Change in balance from baseline
Time frame: 36 weeks
Health-related quality of life
Time frame: Baseline
Change in health-related quality of life from baseline
Time frame: 12 weeks
Change in health-related quality of life from baseline
Time frame: 24 weeks
Change in health-related quality of life from baseline
Time frame: 36 weeks
Self-efficacy for physical activity:
Time frame: Baseline
Change in self-efficacy for physical activity from baseline
Time frame: 12 weeks
Change in self-efficacy for physical activity from baseline
Time frame: 24 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jun 2026.
- Derived from this study: PubMed 40397951Richardson J, Kuspinar A, Sinclair S, Beauchamp M, Dufour S, Tang A, MacDermid J, Durocher E, Thabane L, Xie F, Costa A. Effect of an Online Mobility Self-Management Program on Walking Speed in Older Adults With Preclinical Mobility Limitation: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2025 May 21;14:e72585. doi: 10.2196/72585.
- Individual participant dataSharing planned: No
Related trials for Mobility Limitation
Active, not recruiting
Comparative Effects of Cyriax Approach With and Without Mobilization With Movement in Shoulder Restriction With Rotator Cuff Tendinopathy
Rotator Cuff Tendinopathy
Not yet recruiting
Supplementary Neuromuscular Rehabilitation During Acute Concussion Recovery
Concussion (Diagnosis), Gait Abnormality
Not yet recruiting
Effects of Low-Load Blood Flow Restriction Resistance Training With and Without Hip Abductor Strengthening in Patients With Knee Osteoarthritis.(BFR)
Knee Osteoarthritis
Active, not recruiting
Effects of Blood Flow Restriction Training and Instrument-Assisted Soft Tissue Mobilization for Pain, Strength, Range of Motion, and Kinesiophobia Among ACL Reconstruction Patients.
ACL Reconstruction
Active, not recruiting
Randomized Clinical Trial to Improve Mobility After Hospitalization
Hypertension, Diabetes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Julie Richardson, PhD principal investigator
McMaster University
Ayse Kuspinar, PhD principal investigator
McMaster University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Stepping-Up, Telephone-Based Coaching Walking Program and Chair-Based Yoga Program in people with Mobility Limitation, run by McMaster University at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 17 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Walking speed (time frame: Baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04368949, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jun 2026.